CUSIP 00461U105COMACRSQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
121 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Bml Capital Management, LLC | 14.25M | $42.89M | 0 | Held |
| 2 | Vivo Capital, LLC | 8.89M | $26.76M | 0 | Held |
| 3 | Blackrock, Inc. | 6.80M | $20.48M | +1.11M | Added |
| 4 | Vanguard Group Inc | 6.50M | $19.57M |
| −13.4K |
| Reduced |
| 5 | Rock Springs Capital Management LP | 4.45M | $13.41M | −155.6K | Reduced |
| 6 | Decheng Capital LLC | 4.04M | $12.17M | 0 | Held |
| 7 | Morgan Stanley | 3.42M | $10.28M | −661.9K | Reduced |
| 8 | Adage Capital Partners Gp, L.L.C. | 3.37M | $10.15M | −1.91M | Reduced |
| 9 | Geode Capital Management, LLC | 2.39M | $7.20M | +3.2K | Added |
| 10 | D. E. Shaw & Co., Inc. | 2.10M | $6.31M | −276.6K | Reduced |
See every fund holding Aclaris Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders